Antinuclear antibodies in patients with polymorphic light eruption: A long-term follow-up study

British Journal of Dermatology

Volumn 158, Issue 5, 2008, Pages 1050-1054

  Tzaneva, S ^a   Volc Platzer, B ^c   Kittler, H ^b   Honigsmann H ^a   Tanew, A ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b Universitatsklinik fur Dermatologie   (Austria)

^c NONE   (Austria)

Author keywords

Antinuclear antibodies; Lupus erythematosus; Polymorphic light eruption

Indexed keywords

ANTINUCLEAR ANTIBODY; CELL NUCLEUS ANTIGEN; RO ANTIBODY;

ADULT; ANTIBODY TITER; ARTICLE; DISEASE COURSE; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; PHOTODERMATOSIS; PRIORITY JOURNAL; RISK FACTOR; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; ANTIBODIES, ANTINUCLEAR; BIOLOGICAL MARKERS; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; PHOTOSENSITIVITY DISORDERS;

EID: 42049084843     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2008.08500.x     Document Type: Article

References (17)

1. Berg M. Epidemiological studies of the influence of sunlight on the skin. Photodermatology 1989 6 : 80 4.
2. Morison WL, Stern RS. Polymorphous light eruption: a common reaction uncommonly recognised. Acta Derm Venereol (Stockh) 1982 62 : 237 40.
3. Pao C, Norris PG, Corbett M, Hawk JL. Polymorphic light eruption: prevalence in Australia and England. Br J Dermatol 1994 130 : 62 4.
4. Cahn MM, Levy EJ, Schaffer B. Polymorphous light eruption. Arch Dermatol 1963 88 : 756 8.
5. Jansen CT, Karvonen J. Polymorphous light eruption. Arch Dermatol 1984 120 : 862 5.
6. Mastalier U, Kerl H, Wolf P. Clinical, laboratory, phototest and phototherapy findings in polymorphic light eruption: a retrospective study of 133 patients. Eur J Dermatol 1998 8 : 554 9.
7. Hasan T, Ranki A, Jansen CT, Karvonen J. Disease association in polymorphous light eruption. Arch Dermatol 1998 134 : 1081 5.
8. Murphy GM, Hawk JL. The prevalence of antinuclear antibodies in patients with apparent polymorphic light eruption. Br J Dermatol 1991 125 : 448 51.
9. Petzelbauer P, Binder M, Nikolakis P et al. Severe sun sensitivity and the presence of antinuclear antibodies in patients with polymorphous light eruption-like lesions. J Am Acad Dermatol 1992 26 : 68 74.
10. Tan EM, Cohen AS, Fries JF et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982 25 : 1271 7.
11. Fritzler MJ, Pauls JD, Kinsella TD, Bowen TJ. Antinuclear, anticytoplasmic, and anti-Sjögren's syndrome antigen A (SS-A/Ro) antibodies in female blood donors. Clin Immunol Immunopathol 1985 36 : 120 8.
12. Tan EM, Feltkamp TEW, Smolen JS et al. Range of antinuclear antibodies in 'healthy' individuals. Arthritis Rheum 1997 40 : 1601 11.
13. Craig WY, Ledue TB, Johnson AM, Ritchie RF. The distribution of antinuclear antibody titers in 'normal' children and adults. J Rheumatol 1999 26 : 914 19.
14. Teubner A, Tillmann HL, Schuppan D et al. Prevalence of circulating autoantibodies in healthy individuals. Med Klin 2002 97 : 645 9.
15. Sontheimer R. Subacute cutaneous lupus erythematosus: 25-year evolution of a prototypic subset (subphenotype) of lupus erythematosus defined by characteristic cutaneous, pathological, immunological and genetic findings. Autoimmun Rev 2005 4 : 253 63.
16. Provost TT, Watson R, Simmons-O'Brien E. Significance of the anti-Ro (SS-A) antibody in evaluation of patients with cutaneous manifestations of a connective tissue disease. J Am Acad Dermatol 1996 35 : 147 69.
17. Popovic K, Nyberg F, Wahren-Herlenius M, Nyberg F. A serology-based approach combined with clinical examination of 125 Ro/SSA-positive patients to define incidence and prevalence of subacute cutaneous lupus erythematosus. Arhthritis Rheum 2007 56 : 255 64.